Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator (Q46167525)

20 December 2017

title

Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator (English)

1 reference

20 December 2017

author name string

Olga B Ioffe

series ordinal

1

1 reference

20 December 2017

Richard J Zaino

series ordinal

2

1 reference

20 December 2017

George L Mutter

series ordinal

3

1 reference

20 December 2017

publication date

9 January 2009

1 reference

20 December 2017

published in

Modern Pathology

1 reference

20 December 2017

volume

22

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

450-459

1 reference

20 December 2017

In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone

cites work

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Systematic review of mifepristone for the treatment of uterine leiomyomata

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

The spectrum of endometrial pathology induced by progesterone receptor modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Imaging techniques for evaluation of the uterine cavity and endometrium in premenopausal patients before minimally invasive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

A role for the androgen receptor in the endometrial antiproliferative effects of progesterone antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Long-term progestin-only contraceptives result in reduced endometrial blood flow and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

A three-dimensional study of endometrial microvessels in women using the contraceptive subdermal levonorgestrel implant system, norplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

7 January 2021

Progesterone receptor modulators and the endometrium: changes and consequences

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

7 January 2021

Dating the endometrial biopsy

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

7 January 2021

The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

7 January 2021

Effect of long-term treatment with low-dose mifepristone on the endometrium

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

7 January 2021

Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

7 January 2021

Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

7 January 2021

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2008.204

7 January 2021

10.1038/MODPATHOL.2008.204

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017